Heart Failure—Do We Need New Drugs or Have Them Already? A Case of Coenzyme Q10

Heart failure (HF) is a global epidemic that contributes to the deterioration of quality of life and its shortening in 1–3% of adult people in the world. Pharmacotherapy of HF should rely on highly effective drugs that improve prognosis and prolong life. Currently, the ESC guidelines from 2021 indic...

Descripción completa

Detalles Bibliográficos
Autores principales: Filipiak, Krzysztof J., Surma, Stanisław, Romańczyk, Monika, Okopień, Bogusław
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143244/
https://www.ncbi.nlm.nih.gov/pubmed/35621872
http://dx.doi.org/10.3390/jcdd9050161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143244/
https://www.ncbi.nlm.nih.gov/pubmed/35621872
http://dx.doi.org/10.3390/jcdd9050161

Ejemplares similares